SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
7.78
+0.22 (2.91%)
At close: May 22, 2026, 4:00 PM EDT
7.79
+0.01 (0.13%)
After-hours: May 22, 2026, 7:58 PM EDT

SLS Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
1.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.00M-6.60M-86.84%
Dec 31, 20217.60M5.70M300.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
UroGen Pharma140.49M
KalVista Pharmaceuticals114.48M
Immatics43.00M
Maze Therapeutics20.00M
Revenue Rankings